Lexeo Therapeutics (LXEO) Other Working Capital Changes (2023 - 2026)
Lexeo Therapeutics recorded quarterly Other Working Capital Changes of $17748.0 in Q1 2026, down 99.43% quarter-over-quarter from $3.1 million in Q4 2025, and down 95.1% year-over-year from $362000.0 in Q1 2025.
Lexeo Therapeutics' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $17748.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 95.1% year-over-year to $17748.0; the TTM figure through Mar 2026 stood at $17748.0 (down 99.37% YoY), while the FY2025 annual figure was $80955.0, up 15.27% from the prior year.
- Other Working Capital Changes came in at $17748.0 for Q1 2026 at Lexeo Therapeutics, down from $3.1 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q4 2025 to a low of -$524000.0 in Q1 2023.
- A 4-year average of $384570.1 and a median of $28572.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 2413.21% in 2024 and plunged 95.1% in 2026, its largest moves.
- Lexeo Therapeutics' Other Working Capital Changes stood at $106000.0 in 2023, then surged by 2413.21% to $2.7 million in 2024, then rose by 16.59% to $3.1 million in 2025, then tumbled by 99.43% to $17748.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered $17748.0, $3.1 million, and $14533.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Lexeo Therapeutics | 392.12 Mn | 199.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,748.00 |
| Mar 31, 2026 | 17,748.00 |
| Dec 31, 2025 | 3.11 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 14,533.00 |
| Sep 30, 2025 | 14,533.00 |
| Jun 30, 2025 | 28,572.00 |
| Jun 30, 2025 | 28,572.00 |
| Mar 31, 2025 | 362,000.00 |
| Mar 31, 2025 | 362,000.00 |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Sep 30, 2024 | 65,767.00 |
| Sep 30, 2024 | 65,767.00 |
| Jun 30, 2024 | 45,791.00 |
| Jun 30, 2024 | 45,791.00 |
| Mar 31, 2024 | -315,000.00 |
| Mar 31, 2024 | -315,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Sep 30, 2023 | -485,000.00 |
| Sep 30, 2023 | -485,000.00 |
| Jun 30, 2023 | -87,000.00 |
| Jun 30, 2023 | -87,000.00 |
| Mar 31, 2023 | -524,000.00 |
| Mar 31, 2023 | -524,000.00 |